Aarti Pharmalabs Posts Strong Q4 FY25, Targets Robust Growth in FY25-26
Moneylife Digital Team 27 May 2025
Aarti Pharmalabs Limited (APL), a leading manufacturer of active pharmaceutical ingredients (APIs), pharmaceutical intermediates and xanthine derivatives, reported an 11% year-on-year (y-o-y)...
Archived Premium Content
This article is outside your subscription period. You can buy this article individually.
SINGLE ARTICLE
Rs 50-Rs 100 + GST
Access will be given ONLY to this article.
 
Get access to complete archives
Rs 5000 + GST
 
 
Already a subscriber ? Log in
Free Helpline
Legal Credit
Feedback